OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review
Sebastiano A. G. Lava, Craig Laurence, Alessandro Di Deo, et al.
Pediatric Drugs (2024) Vol. 26, Iss. 3, pp. 229-243
Closed Access | Times Cited: 6
Sebastiano A. G. Lava, Craig Laurence, Alessandro Di Deo, et al.
Pediatric Drugs (2024) Vol. 26, Iss. 3, pp. 229-243
Closed Access | Times Cited: 6
Showing 6 citing articles:
The efficacy of sodium-glucose transporter 2 inhibitors in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
Hongsheng Li, Yanli Hou, Xin Wang, et al.
Pharmacological Research (2025) Vol. 213, pp. 107647-107647
Open Access | Times Cited: 1
Hongsheng Li, Yanli Hou, Xin Wang, et al.
Pharmacological Research (2025) Vol. 213, pp. 107647-107647
Open Access | Times Cited: 1
Drug Development in Pediatric Chronic Kidney Disease: A Review of Promising Treatments, Old Challenges, and New Strategies
Alexander J. Kula
Pediatric Drugs (2025)
Closed Access | Times Cited: 1
Alexander J. Kula
Pediatric Drugs (2025)
Closed Access | Times Cited: 1
Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near
Gilda M. Portalatin, Irene Hong‐McAtee, Anna Burgner, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access
Gilda M. Portalatin, Irene Hong‐McAtee, Anna Burgner, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access
Effect of empagliflozin treatment on laboratory and clinical findings of patients with glycogen storage disease type Ib: first study from Türkiye
Engi̇n Köse, Figen Özçay, Halil İbrahim Aydın, et al.
Journal of Pediatric Endocrinology and Metabolism (2025)
Closed Access
Engi̇n Köse, Figen Özçay, Halil İbrahim Aydın, et al.
Journal of Pediatric Endocrinology and Metabolism (2025)
Closed Access
Treatment experience with dapagliflozin in pediatric patients with heart failure in four different etiologies: Case series
Kamila Kurkiewicz-Sawczak, Weronika Pelczar-Płachta, Filip Sawczak, et al.
Kardiologia Polska (2024) Vol. 82, Iss. 10, pp. 1003-1005
Open Access
Kamila Kurkiewicz-Sawczak, Weronika Pelczar-Płachta, Filip Sawczak, et al.
Kardiologia Polska (2024) Vol. 82, Iss. 10, pp. 1003-1005
Open Access
Successful repurposing of empagliflozin to treat neutropenia in a severe congenital neutropenia patient with G6PC3 mutations
Grigorios Tsaknakis, Erasmia Boutakoglou, Irene Mavroudi, et al.
Metabolism (2024), pp. 156077-156077
Closed Access
Grigorios Tsaknakis, Erasmia Boutakoglou, Irene Mavroudi, et al.
Metabolism (2024), pp. 156077-156077
Closed Access
